Advertisement
외환 뉴스
Japan Industrial Output Rises 1.0% In October
Industrial production in Japan was up a seasonally adjusted 1.0 percent on month in October, the Ministry of Economy, Trade and Industry said on Thursday - exceeding forecasts for an increase of 0.8 percent and up from 0.5 percent in September.
RTTNews |
561 일 전
Singapore Shares Likely Rangebound On Thursday
The Singapore stock market on Wednesday ended the four-day losing streak in which it had slumped almost 50 points or 1.6 percent. The Straits Times Index now sits just beneath the 3,085-point plateau and it's expected to see little movement on Thursday.
RTTNews
|
561 일 전
Steady Start Anticipated For Malaysia Shares
The Malaysia stock market has moved lower in three straight sessions, slipping almost 8 points or 0.6 percent along the way. The Kuala Lumpur Composite Index now sits just above the 1,445-point plateau although it may find its footing on Thursday.
RTTNews
|
561 일 전
South Korea Shares May Be Stuck In Neutral On Thursday
The South Korea stock market turned slightly lower again on Wednesday, one day after snapping the two-day losing streak in which it had slipped almost 20 points or 0.8 percent. The KOSPI now sits just beneath the 2,520-point plateau and it's likely to remain in that neighborhood again on Thursday.
RTTNews
|
561 일 전
Japan Data On Tap For Thursday
Japan is scheduled to release a raft of data on Thursday, highlighting a busy day for Asia-Pacific economic activity. On tap are October numbers for industrial production, retail sales, construction orders and housing starts, as well as November results for its consumer confidence index.
RTTNews
|
561 일 전
U.S. Dollar Showing Modest Move Back To The Upside
After trending lower over the past few days, the value of the U.S. dollar has moved modestly higher over the course of trading on Wednesday.
RTTNews
|
561 일 전
Euro Weakens As German Inflation Eases More Than Expected
The euro fell against its major counterparts in the New York session on Wednesday, as German inflation eased in November to the lowest level in nearly two-and-a-half years.
RTTNews
|
561 일 전
more news
Canadian Market Modestly Higher At Noon
The Canadian market is turning in a mixed performance on Wednesday. While optimism about the outlook for interest rates contribute a bit to market's rise, growth worries and caution ahead of some crucial U.S. and Canadian economic data appear to be limiting the upside.
RTTNews
|
561 일 전
U.S. Dollar Erases Losses Against Majors
The U.S. dollar rose against its most major counterparts in the European session on Wednesday, after falling in the previous session on the back of dovish remarks from Fed Governor Christopher Waller.
RTTNews
|
561 일 전
AbbVie Announces Topline Results From Phase 2 LUMINOSITY Trial Of Telisotuzumab-Vedotin
Biopharmaceutical company AbbVie, Inc. (ABBV) announced Wednesday topline results from the single-arm Phase 2 LUMINOSITY trial evaluating telisotuzumab-vedotin (Teliso-V) in patients with c-Met protein overexpression, epidermal growth factor receptor (EGFR) wild type, advanced/metastatic nonsquamous non-small cell lung cancer (NSCLC). The trial demonstrated compelling clinical benefits across key endpoints.
RTTNews
|
561 일 전
Philips' Stock Hit By FDA Warning Against DreamStation 2 CPAP Machines
Shares of Philips Electronics NV were losing around 5 percent in Amsterdam trading as well as in the pre-market activity on the NYSE after the U.S. regulator warned against the safety of Dutch consumer electronics giant's DreamStation 2 Continuous Positive Airway Pressure or CPAP Machines. The Food and Drug Administration or FDA said it is alerting patients and healthcare providers of an emerging
RTTNews
|
562 일 전
Pasithea Announces Receipt Of FDA Response Of Pre-IND Meeting For PAS-004 Clinical Development
Biotechnology company Pasithea Therapeutics Corp. (KTTA) announced Wednesday receipt of written responses to questions submitted for a Type 2 pre-Investigational New Drug Application (IND) meeting with the U.S. Food and Drug Administration (FDA) regarding clinical development plan for PAS-004.
RTTNews
|
562 일 전
UniQure Says FDA Clears IND Application For AMT-191 Gene Therapy For Fabry Disease
Gene therapy company uniQure N.V. (QURE) announced Wednesday that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for AMT-191, the Company's gene therapy candidate for Fabry disease.
RTTNews
|
562 일 전
Stay up to date!
Add 뉴스 to your browser
Add To Chrome
